icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Thu 25 Jun 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Government websites use the protocol. HTTPS for encryption and security.

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Registered with the Digital Government Authority under number:
20250831619
Suggestions

Bi-weekly Cetuximab and XELIRI(Capecitabine and Irinotecan) as first line therapy in K/N-RAS wild type advanced colorectal cancer: Phase I-II CETUXIRI study

Bi-weekly Cetuximab and XELIRI(Capecitabine and Irinotecan) as first line therapy in K/N-RAS wild type advanced colorectal cancer: Phase I-II CETUXIRI study

icon 2022-06-29
عنوان الدراسة
Bi-weekly Cetuximab and XELIRI(Capecitabine and Irinotecan) as first line therapy in K/N-RAS wild type advanced colorectal cancer: Phase I-II CETUXIRI study
داعم الدراسة
King Faisal Specialist Hospital and Research Centre
دواء الدراسة
Cetuximab
رقم بروتوكول الدراسة
1 , 29/07/2015
حالة الدراسة
Completed
موقع الدراسة
KFSH&RC-R
مرحلة الدراسة
1/2

Comments and Suggestions

For any inquiries or comments about the government services, please fill in the required information.

Last update date: 01/08/2024 at 04:03 AM Saudi Arabia time